SASMAR kondigt de overname van Aquatrove BioSciences, Inc. aan mrt. 16, 2017 Pharmaceutical company SASMAR acquires biotechnology company Aquatrove Biosciences, Inc. strengthening its global position in over-the-counter products that support health, fertility and reproduction.... Acquisitions Aquatrove Biosciences Lees meer
Farmaceutisch bedrijf kiest om in Australië te produceren, om de economie thuis te stimuleren mrt. 16, 2017 Sasmar, an Australian biotechnology company, announced today that is has moved all manufacturing of its family planning lines to the Australian market. Sasmar CEO John-Michael Mancini said, With many... Australia economy family planning Lees meer